MMED · TickerCove

MMEDMiniMed Group, Inc. Common StockHealthcare · Medical - Equipment & Servicesas of 2026-09-16

Horizon

Issued 2026-09-16 at $22.40 · now $22.40 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, MMED has typically landed between $17.53 and $29.75 — a range of −21.8% to +32.8% from the issuance price $22.40.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

113 overlapping 1 month windows · 2026-03-06 – 2026-08-17 · basis climatology · forecast (batch).

The cone is anchored at the 2026-09-16 issuance close ($22.40) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$22.4 · 89% of range

$10.8 low$23.84 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Distribution ranges onlyiThis name has too little trading history to publish a calibrated probability, so we show its distribution ranges only — no directional call. Its record is still building.

No directional probability — ranges below.

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

+12.2%

typical move · IQR 36.5%

−21.8%worst (p90)+32.8%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where MMED has typically landed a month from the 2026-09-16 close of $22.4 — the range is history, not a prediction.

now $22.4 (+0.0%)
typical $25.14 (+12.2%)
middle 50% $21.06–$29.23
90% range $17.53–$29.75

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 113 windows spanning 2026-03-06 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2026-03-06	−28.6%	−28.6%	+0.0%
2026-04-15	−27.2%	−27.2%	+0.0%
2026-04-14	−26.5%	−26.6%	+0.1%
3 best
2026-07-14	+37.6%	+0.0%	+37.6%
2026-05-15	+36.1%	+0.0%	+43.2%
2026-05-19	+35.6%	−0.8%	+42.1%

113 overlapping windows · 2026-03-06 – 2026-09-16 · not cherry-picked

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

90 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-07-31	Dallara Que	director	Withheld for tax	31,350	884,749	Form 4
2026-07-31	Dianaty Ali	officer	Withheld for tax	8,012	315,158	Form 4
2026-07-31	Wills Courtney Nelson	officer	Withheld for tax	1,762	136,384	Form 4
2026-07-28	Spooner Chad	officer	Withheld for tax	23,301	362,707	Form 4
2026-07-28	Chandrasena Gillian	officer	Withheld for tax	2,099	172,745	Form 4
2026-07-01	Chandrasena Gillian	officer	Award / grant	29,483	160,139	Form 4
2026-07-01	Chandrasena Gillian	officer	Award / grant	14,705	174,844	Form 4
2026-07-01	Dallara Que	director	Award / grant	297,618	916,099	Form 4
2026-07-01	Dianaty Ali	officer	Award / grant	94,550	286,408	Form 4
2026-07-01	Dianaty Ali	officer	Award / grant	36,762	323,170	Form 4
2026-07-01	Gyurci John	officer	Award / grant	24,244	39,941	Form 4
2026-07-01	Wills Courtney Nelson	officer	Award / grant	60,730	116,089	Form 4
2026-07-01	Wills Courtney Nelson	officer	Award / grant	22,057	138,146	Form 4
2026-07-01	Spooner Chad	officer	Award / grant	94,550	363,951	Form 4
2026-07-01	Spooner Chad	officer	Award / grant	22,057	386,008	Form 4
2026-03-25	Dallara Que	director	Withheld for tax	4,809	616,754	Form 4
2026-03-11	Chandrasena Gillian	officer	Award / grant	11,486	11,486	Form 4
2026-03-11	Gyurci John	officer	Award / grant	15,322	15,322	Form 4
2026-03-11	Dallara Que	director	Award / grant	51,044	51,044	Form 4
2026-03-11	Dallara Que	director	Award / grant	22,892	22,892	Form 4
2026-03-11	Dianaty Ali	officer	Award / grant	11,054	11,054	Form 4
2026-03-11	Dianaty Ali	officer	Award / grant	46,989	46,989	Form 4
2026-03-11	Dianaty Ali	officer	Award / grant	35,448	35,448	Form 4
2026-03-11	Dianaty Ali	officer	Award / grant	14,628	14,628	Form 4
2026-03-11	Dianaty Ali	officer	Award / grant	33,684	33,684	Form 4
2026-03-11	Dianaty Ali	officer	Award / grant	35,448	35,448	Form 4
2026-03-11	Dianaty Ali	officer	Award / grant	11,563	11,563	Form 4
2026-03-11	Dianaty Ali	officer	Award / grant	2,444	2,444	Form 4
2026-03-11	Wills Courtney Nelson	officer	Award / grant	18,082	18,082	Form 4
2026-03-11	Wills Courtney Nelson	officer	Award / grant	955	955	Form 4
2026-03-11	Wills Courtney Nelson	officer	Award / grant	5,151	5,151	Form 4
2026-03-11	Dallara Que	director	Award / grant	281,937	281,937	Form 4
2026-03-11	Dallara Que	director	Award / grant	127,609	127,609	Form 4
2026-03-11	Dallara Que	director	Award / grant	57,239	57,239	Form 4
2026-03-11	Dallara Que	director	Award / grant	80,842	80,842	Form 4
2026-03-11	Dallara Que	director	Award / grant	51,044	51,044	Form 4
2026-03-11	Dallara Que	director	Award / grant	22,892	22,892	Form 4
2026-03-11	Chandrasena Gillian	officer	Award / grant	11,486	11,486	Form 4
2026-03-11	Chandrasena Gillian	officer	Award / grant	19,852	19,852	Form 4
2026-03-11	Chandrasena Gillian	officer	Award / grant	28,116	28,116	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.